Lung bioavailability of chlorofluorocarbon free, dry powder and chlorofluorocarbon containing formulations of salbutamol

British Journal of Clinical Pharmacology

Volumn 41, Issue 3, 1996, Pages 247-249

  Clark, D J ^a   Lipworth, B J ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Chlorofluorocarbon; Dry powder inhaler; Lung bioavailability; Metered dose inhaler; Salbutamol

Indexed keywords

FLUOROCARBON; SALBUTAMOL;

ADULT; ARTICLE; BIOAVAILABILITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG FORMULATION; DRUG URINE LEVEL; HUMAN; HUMAN EXPERIMENT; INHALATIONAL DRUG ADMINISTRATION; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0030000538     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2125.1996.tb00191.x     Document Type: Article

References (10)

1. Partridge MR. Metered-dose inhalers and CFCs: what respiratory physicians need to know. Respir Med 1994; 88: 645-647.
2. Melchor R, Biddiscombe MF, Mak VHF, Short MD, Spiro SG. Lung deposition patterns of directly labelled salbutamol in normal subjects and in patients with reversible airflow obstruction. Thorax 1993; 48: 506-511.
3. June D. A new generation of inhaler technology. Br J Clin Practice 1995; (Suppl 79): 18-21.
4. Hindle M, Chrystyn H. Determination of the relative bioavailability of salbutamol to the lung following inhalation. Br J Clin Pharmacol 1992; 34: 311-315.
5. Lipworth BJ, McDevitt DG. Beta-adrenoceptor responses to inhaled salbutamol in normal subjects. Eur J Clin Pharmacol 1989; 36: 239-245.
6. Lipworth BJ, Clark RA, Dhillon DP et al. Pharmacokinetics, efficacy and adverse effects of sublingual salbutamol in patients with asthma. Eur J Clin Pharmacol 1989; 37: 567-571.
7. 2-adrenoceptor responses and pharmacokinetics of salbutamol given by standard metered-dose inhaler and modified actuator device. Br J Clin Pharmacol 1993; 36: 445-450.
8. Newman SP, Weisz A, Clarke SW. Bronchodilator delivery from Gentlehaler, a new low velocity pressurised aerosol inhaler. Chest 1993; 103: 1442-1446.
9. Tansey I. Technological development of airomir (salbutamol sulphate in CFC free system) MDI. Br J Clin Practice 1995; (Suppl 79): 13-15.
10. Clark DJ, Gordon-Smith J, McPhate G, Clark GA, Lipworth BJ. Lung bioavailability of generic and innovator formulations of inhaled salbutamol. Eur Resp J 1995; 8 (suppl 19): 259s.